Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kyriakos Karypidis"'
Autor:
Giorgos Kouvatseas, Christos Smias, Panayotis Kaloyannidis, Kyriakos Karypidis, Despoina Mallouri, Achilles Anagnostopoulos, Evangelia Yannaki, Vasiliki Douka, Ioanna Sakellari, Damianos Sotiropoulos, Michalis Iskas, P. Baliakas, Chrysa Apostolou, Anastasia Marvaki, Ioannis Batsis, Varnavas Konstantinou, Eleni-Maria Abela
Publikováno v:
Leukemia & Lymphoma. 56:3071-3081
Optimal conditioning remains a challenge in lymphomas. We designed a regimen consisting of Busulfex, etoposide and melphalan (BuEM). We retrospectively analyzed the outcome of patients conditioned with carmustine, etoposide, cytarabine and melphalan
Autor:
Anastasia Marvaki, Panayiotis Kaloyannidis, Despina Mallouri, Kyriakos Karypidis, Christos Smias, Evangelia Yannaki, Ioanna Sakellari, Achilles Anagnostopoulos, Iskas Michail, George Kouvatseas, Vassiliki Douka, P. Baliakas, Elma Maria Abela, Ioannis Batsis, Chryssoula Apostolou, Varnavas Konstantinou
Publikováno v:
Journal of Clinical Oncology. 31:8567-8567
8567 Background: In autologous hematopoietic cell transplantation (AHCT) for lymphomas, the optimal conditioning regimen is currently investigated. The standard conditioning used is BEAM. During 2009-2011 a new alternative Busulphan-based conditionin
Autor:
Ioannis Batsis, Varnavas Konstantinou, Anastasia Marvaki, Mihail Iskas, Vasiliki Douka, Evaggelia Yannaki, Ioanna Sakellari, Damianos Sotiropoulos, Elissavet Georgiadou, Eleni-Maria Abela, Kyriakos Karypidis, Panayiotis Kaloyannidis, P. Baliakas, Despina Mallouri, Chrysa Apostolou, Achilles Anagnostopoulos
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S238-S239
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.